Burkina Faso has announced a new significant reduction in the prices of essential generic medicines and certain medical consumables, with cuts reaching up to 72%.
Backed by a financial effort of 3 billion CFA francs, the measure will take effect on March 1, 2026, in order to strengthen equitable access to healthcare.
Following the Council of Ministers meeting held on February 12, 2026, the authorities decided to significantly lower the prices of essential generic medicines, specific health products, and medical consumables distributed by the Central Purchasing Agency for Essential Generic Medicines (CAMEG). The measure will come into force on March 1, 2026.
According to the Minister of Health, Dr. Robert Lucien Jean-Claude Kargougou, the reductions vary by category: up to 67.27% for certain tablet forms, 53.47% for injectable products, 20% for syrups and suspensions, and up to 72.73% for certain medical consumables.
To support this reform, the government is mobilizing financial assistance estimated at 3 billion CFA francs. The initiative aims to reduce the burden of healthcare expenses on households, improve access to treatment, and strengthen equity in the provision of care.
This new price reduction follows a previous one implemented in May 2025, whose budgetary impact was estimated at nearly 5 billion CFA francs. It is part of the authorities’ commitment to ensuring quality healthcare accessible to all citizens.